MENU
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals Inc discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
64.27B
P/E Ratio
15.27
Total Cash
9.01B
Projected Growth
0.93
Total Debt
2.7B
Revenue
14.2B
Risk (Beta)
0.35
Dividend Yield
0.00
Total Cash/Share
82.44
Total Debt/Equity
24.02
Revenue/Share
123.39 USD as % of share price
Fundamentals
REGN
Capitalization
64.3B
P/E Ratio
15.27
Risk (Beta)
0.35
Dividend Yield
0.00
Total Cash
9.01B
Total Cash/Share
82.44
Total Debt
2.7B
Total Debt/Equity
24.02
Projected Growth (PEG Ratio)
0.93
Revenue/Share (as % of the share price)
123.39%
Revenue
14.2B
ROE
N/A
Book Value
29.4B
P/B Ratio
2.18
Cash Flow
N/A
Earnings
40.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
4.73
Current Revenue Per Employee
250840.72
Dividends Per Share - Security
N/A
EBITDA
5.32B
Float
N/A
Float - Current
N/A
Gross Income Margin
85.08
Revenue To Assets
12.46
Shares Held By Institutions
209B
Shares Outstanding - Current
109M
Total Liabilities
8.41B
Total Volume MTD
N/A
Value
1
Gain YTD
-17.369
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of medicines for the treatment of serious medical conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com